Lin Pei
-
- Pituitary Gland Disorders and Treatments 9
- Growth Hormone and Insulin-like Growth Factors 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 10
- Genetics top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 7
- Ion Transport and Channel Regulation 3
- Immunology top 10%
-
- Liver Disease Diagnosis and Treatment 4
-
- Neuroblastoma Research and Treatments 4
-
- Reproductive Biology and Fertility 3
Lin Pei
46 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 844
- Cancer Research 478
- Genetics 296
- Molecular Biology 1.3k
- Immunology 396
Countries citing papers authored by Lin Pei
This map shows the geographic impact of Lin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Pei more than expected).
Fields of papers citing papers by Lin Pei
This network shows the impact of papers produced by Lin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Pei. The network helps show where Lin Pei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 0 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 35 | |
| 7 | 2021 | 46 | |
| 8 | 2019 | 47 | |
| 9 | 2018 | 32 | |
| 10 | 2017 | 56 | |
| 11 | 2011 | 54 | |
| 12 | 2010 | 182 | |
| 13 | 2009 | 233 | |
| 14 | 2003 | 208 | |
| 15 | 2001 | 132 | |
| 16 | 2000 | 65 | |
| 17 | 2000 | 4 | |
| 18 | 1998 | 15 | |
| 19 | 1997 | 17 | |
| 20 | 1994 | 3 |
About Lin Pei
Lin Pei is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Physiology, Nephrology and Molecular Biology, having authored 48 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), Pituitary Gland Disorders and Treatments (9 papers), Epigenetics and DNA Methylation (7 papers), Liver Disease Diagnosis and Treatment (4 papers), Neuroblastoma Research and Treatments (4 papers), Reproductive Biology and Fertility (3 papers), Ion Transport and Channel Regulation (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (844 citations), Cancer Research (478 citations), Genetics (296 citations), Molecular Biology (1.3k citations) and Immunology (396 citations). Lin Pei has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Шломо Мелмед, B. Scheithauer, Kálmán Kovács, Wenwen Chien, Dara Kallop, Timothy Hoey, Scott Powers, Jinfeng Liu, Mei Jia and Kelly E. Mayo. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, Molecular Endocrinology, The Journal of Clinical Endocrinology & Metabolism and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.